Table 3.
Hemodynamic changes using repeated measure analysis
| Variable | HR | MAP | ||||
|---|---|---|---|---|---|---|
| Group | MO | M | O | MO | M | O |
| 5 min before SA | 91.46 ± 17.48 | 94.63 ± 17.7 | 97.63 ± 16.37 | 84.08 ± 11.36 | 79.4 ± 16.58 | 80.76 ± 20.4 |
| After SA | 91.46 ± 16.93 | 95.2 ± 19.25 | 97.33 ± 14.1 | 79.14 ± 13.6 | 81.04 ± 15.79 | 76.76 ± 17.05 |
| 10 min after drug | 97 ± 15.57 | 93.33 ± 16.42 | 100.66 ± 1378 | 79.1 ± 12.68 | 80.23 ± 11.41 | 76.64 ± 15.49 |
| 20 min after drug | 96.56 ± 14.9 | 96.56 ± 14.9 | 101.26 ± 13.7 | 70.91 ± 13.72 | 75.67 ± 12.78 | 73.94 ± 14.7 |
| P value | 0.23 | 0.38 | ||||
SA spinal anesthesia, HR beat per minute, MAP mean arterial pressure, M misoprostol, O oxytocin, MO combined misoprostol–oxytocin